Devices › Stimulator, electrical, implanted, for parkinsonian symptoms
Device brand name · Stimulator electrical implanted for parkinsonian tremor
Vercise Genus: medical device reports filed with FDA
1,014 reports name it, 2021–2026. Manufacturer given most often on reports: Boston Scientific Neuromodulation. Product code NHL.
- 1,014
- device reports naming the brand
- 0% of all MAUDE reports · about 193 a year
- 338
- reports, 12 months to August 2026
- 236 in the 12 months before
- 17.2%
- classified as malfunction
- 9.9% across the product code
- 2.4%
- classified as death, as reported
- 24 reports · not verified by FDA
FDA's MAUDE database holds 1,014 reports that name the brand "Vercise Genus" (stimulator electrical implanted for parkinsonian tremor), received between April 2021 and August 2026; the manufacturer given most often on reports is Boston Scientific Neuromodulation. Spellings of one product vary from report to report.
338 reports arrived in the 12 months to August 2026, up 43% from 236 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (80.5%), malfunction (17.2%) and death (2.4%); across all stimulator, electrical, implanted, for parkinsonian symptoms reports (product code NHL) death is recorded in 2.3% and malfunction in 9.9%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are unexpected therapeutic results (25.9%), battery problem (13.3%) and charging problem (7.2%). The patient problems coded most often are shaking/tremors, bacterial infection and discomfort. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 1,824 reports carrying product code NHL. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Unexpected therapeutic results | 263 | 25.9% | 18.3% |
| Battery problema problem with the battery | 135 | 13.3% | 3.4% |
| Charging problem | 73 | 7.2% | 4.4% |
| Wireless communication problema wireless connection problem | 59 | 5.8% | 3.4% |
| Migrationthe device moved from where it was placed | 54 | 5.3% | 7.5% |
| High impedance | 49 | 4.8% | 8.3% |
| Intermittent energy output | 48 | 4.7% | 1.9% |
| Inappropriate/inadequate shock/stimulation | 41 | 4% | 2.3% |
| Inappropriate or unexpected reset | 40 | 3.9% | 1.1% |
| Premature discharge of battery | 34 | 3.4% | 1.6% |
| Off-label use | 19 | 1.9% | 0.9% |
| Overheating of device | 10 | 1% | 0.6% |
| Delayed charge time | 9 | 0.9% | 0.6% |
| Positioning problem | 7 | 0.7% | 0.4% |
| Device displays incorrect message | 5 | 0.5% | 0.3% |
| Nonstandard device | 5 | 0.5% | 0.5% |
| Power problem | 3 | 0.3% | 0.1% |
| Low impedance | 2 | 0.2% | 0.5% |
| Defective devicethe device was defective | 1 | 0.1% | 0.8% |
| Device contaminated during manufacture or shipping | 1 | 0.1% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Shaking/tremors | 131 | 12.9% |
| Bacterial infectiona bacterial infection | 123 | 12.1% |
| Discomfortdiscomfort | 77 | 7.6% |
| Swelling/ edema | 71 | 7% |
| Movement disorder | 69 | 6.8% |
| Undesired nerve stimulation | 57 | 5.6% |
| Erythemaskin redness | 48 | 4.7% |
| Painpain, site not specified | 48 | 4.7% |
| Purulent discharge | 30 | 3% |
| Fluid discharge | 26 | 2.6% |
| Speech disordera speech problem | 25 | 2.5% |
| Impaired healingslow healing | 23 | 2.3% |
| Implant pain | 23 | 2.3% |
| Erosion | 22 | 2.2% |
| Falla fall | 22 | 2.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Vercise Genus | Product code NHL | All MAUDE reports |
|---|---|---|---|
| Reports | 1,014 | 1,824 | 26,136,888 |
| Share of that pool | — | 55.6% | 0% |
| Classified as death, per 1,000 reports | 24 | 23 | 9 |
| Classified as injury | 80.5% | 87.7% | 36.2% |
| Classified as malfunction | 17.2% | 9.9% | 62.3% |
| Filed by the manufacturer | 100% | 97.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code NHL
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Vercise? Cartesia? | 908 | 132 | 2.4% |
| Vercise Gevia? | 355 | 26 | 2.3% |
| Vercise | 274 | 43 | 0.4% |
| Vercise Pc | 156 | 15 | 1.3% |
| SureTek? | 151 | 31 | 0% |
| Infinity 7 Implantable Pulse Generator | 1,258 | 147 | 0.5% |
| Infinity 5 Implantable Pulse Generator | 320 | 22 | 0.6% |
| Dbs | 239 | 0 | 2.9% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Vercise Genus reports
How many FDA reports name Vercise Genus?
1,014 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 338 in the latest 12 months.
What kinds of events are reported?
injury (80.5%), malfunction (17.2%) and death (2.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
unexpected therapeutic results (25.9%), battery problem (13.3%), charging problem (7.2%), wireless communication problem (5.8%) and migration (5.3%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Vercise Genus was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.